Compound ID | 501
Class: Bacterial topoisomerase inhibitor (2-hydroxyisoquinolone)
| Spectrum of activity: | Gram-positive |
| Institute where first reported: | Parke-Davis Pharmaceutical (Pfizer, USA) |
| Year first mentioned: | 2000 |
| Development status: | Inactive |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| Citation: | https://www.drugfuture.com/synth/syndata.aspx?ID=293726 |